Access Insights Conference

Blue Fin Group exec speaks on his upcoming feature.

Blue Fin Group executive highlights how leaders can plan for immediate profitable lifecycles and beyond.

SVP and Managing Director for Blue Fin Group offers a synopsis of the conference opener.

Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.

Conference presentation explores groundbreaking topics impacting the pharma industry.

Director of Berkeley Research Group explains changes to 340B moving forward.

Berkeley Research Group executive speaks about the role of manufacturers in 340B pricing.

Berkeley Research Group Director discusses what to expect at his upcoming session.

Session explores how on-market products have done, and what to expect from new biosimilars.

Conference session discusses the drivers, practical considerations, success factors, and landscape for next-generation pharmacy innovation.

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.